Le Lézard
Classified in: Covid-19 virus
Subjects: LEG, CPN

Congressional Candidate Laura Loomer Raises 2.5x's More Than Democrat Incumbent For The Third Time Despite Pandemic Slowdown


PALM BEACH, Fla., April 16, 2020 /PRNewswire/ -- Laura Loomer, Republican candidate for Congress in Florida's 21st District, home to President and Mrs. Trump, announced that her campaign has raised $204,786 in the 1ST Quarter of 2020, outraising Democrat Incumbent Lois Frankel and her Republican opponents COMBINED for a third time.  Frankel raised only $82,876.  Special interest PAC's represented 72% of Frankel's 1st Quarter revenue.

On March 9th, Loomer's campaign was the first federal campaign in the nation to temporarily halt events and public activities like door knocking due to the Coronavirus pandemic.  Loomer instructed volunteers and staff to assist with community needs such as blood drives and mask making for first responders.

Fundraising was deprioritized by the campaign as well in order to shift focus to community assistance.  Despite the shift, Loomer's campaign reported the largest fundraising total since starting the race for Florida's 21st Congressional seat.

During this cycle to date, 10,790 donations have been received by the campaign from all 50 states with Florida residents being the top contributors.  The average contribution was $52 proving widespread support among the voting public.

Loomer stated, "We're doing all that we can to assist residents in the 21st  District.  Palm Beach County is now Florida's top COVID-19 'hot spot' and we must be vigilant and responsible for ourselves and each other if we are to expedite our recovery and return to normalcy.  While Congresswoman Frankel works to obstruct their efforts, I am confident that under President Trump and Governor DeSantis's leadership this will happen sooner rather than later.  To assist in these efforts, I will continue to divert campaign resources, staff, volunteers and activities to help all who are in need."

Karen Giorno, President Trump's 2016 Florida State Director and chief strategist for the Loomer campaign commented, "I don't know how Lois Frankel is spending her time at home, but in my career, I've never seen a challenger outraise a four-term incumbent by such a massive margin.  Frankel is sitting back, relying on checks from special interests and doing absolutely nothing to prove community support in our district.  It's insulting.  Is Frankel even running?"

Loomer's campaign has outraised Democrat incumbent Lois Frankel, as well as all primary challengers combined for the third quarter in a row, making her the undeniable Republican frontrunner despite being shut down by Big Tech on Facebook, Twitter, Instagram and Paypal.

Giorno continued, "Many of our staff and contractors have agreed to reduced compensation without even being asked out of respect for Laura's leadership as well as respect for our donors who are going through tough times.  Their selflessness inspired me to max out to the campaign with a $5,600 donation.  I am honored to be a part of this historic and important campaign."

Loomer's campaign has contacted supporters through phone, text, email, Telegram, Parler and Gab over 9 million times during the election season with campaign updates, calls-to-action and requests for donations. 

Loomer closed by saying, "During these challenging times, we are reminded now more than ever that elections matter, and strong leadership is essential.  My campaign is committed to winning this Congressional seat, and when I'm elected, I will always people before politics, partisanship and party."

Contact: [email protected]

SOURCE Laura Loomer for Congress


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: